Form 8-K - Current report:
SEC Accession No. 0001193125-23-264152
Filing Date
2023-10-26
Accepted
2023-10-26 16:50:00
Documents
14
Period of Report
2023-10-26
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d537796d8k.htm   iXBRL 8-K 27877
2 EX-3.1 d537796dex31.htm EX-3.1 175793
3 EX-3.2 d537796dex32.htm EX-3.2 248403
  Complete submission text file 0001193125-23-264152.txt   658286

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA tyra-20231026.xsd EX-101.SCH 2830
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE tyra-20231026_lab.xml EX-101.LAB 18724
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tyra-20231026_pre.xml EX-101.PRE 11691
8 EXTRACTED XBRL INSTANCE DOCUMENT d537796d8k_htm.xml XML 3550
Mailing Address 2656 STATE STREET CARLSBAD CA 92008
Business Address 2656 STATE STREET CARLSBAD CA 92008 (619) 728-4760
Tyra Biosciences, Inc. (Filer) CIK: 0001863127 (see all company filings)

EIN.: 831476348 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40800 | Film No.: 231350825
SIC: 2834 Pharmaceutical Preparations